Get the Stockscreener App
7.4416
12.58%
0.8316
Trinity Biotech Plc Adr stock is traded at $7.4416, with a volume of 8,634.
It is up +12.58% in the last 24 hours and up +1.59% over the past month.
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has three segments, namely the Americas, Asia/Africa, and Europe, from which it derives a majority of its revenue from the Americas segment.
See More
Previous Close:
$6.61
Open:
$6.22
24h Volume:
8,634
Relative Volume:
0.47
Market Cap:
$6.05M
Revenue:
$43.86M
Net Income/Loss:
$-37.43M
P/E Ratio:
-3.6891
EPS:
-2.0172
Net Cash Flow:
$-12.50M
1W Performance:
+23.21%
1M Performance:
+1.59%
6M Performance:
-64.71%
1Y Performance:
-77.45%
1-Day Range:
$6.2101
$7.6037
1-Week Range:
$6.05
$7.6916
52-Week Range:
$5.01
$52.50
Trinity Biotech Plc Adr Stock (TRIB) Company Profile
Name
Trinity Biotech Plc Adr
Sector
Industry
Phone
-
Address
-
Compare TRIB vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TRIB
Trinity Biotech Plc Adr
|
7.4416 | 6.05M | 43.86M | -37.43M | -12.50M | -2.0172 |
ABT
Abbott Laboratories
|
104.59 | 180.98B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
95.30 | 121.90B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
291.61 | 111.85B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.80 | 63.48B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.65 | 49.95B | 6.30B | 1.07B | 1.09B | 1.8406 |
Trinity Biotech Plc Adr Stock (TRIB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-23-15 | Downgrade | Craig Hallum | Buy → Hold |
| Sep-03-15 | Initiated | Raymond James | Outperform |
| Jul-29-15 | Reiterated | ROTH Capital | Buy |
| Jul-22-08 | Reiterated | Roth Capital | Buy |
| Mar-17-08 | Reiterated | Roth Capital | Buy |
| Dec-10-07 | Reiterated | Roth Capital | Buy |
| Oct-26-07 | Reiterated | Roth Capital | Buy |
View All
Trinity Biotech Plc Adr Stock (TRIB) Latest News
Total debt of Trinity Biotech Plc Sponsored ADR Class A – GETTEX:TRB0 - TradingView
Trinity Biotech Reports Unanimous Shareholder Approval at 2026 AGM - Kalkine Media
All resolutions passed as Trinity Biotech (TRIB) shareholders reappointed a director. - Stock Titan
Trinity Biotech stock gained 21.32 percent on October 5, 2026 - AD HOC NEWS
EBITDA of Trinity Biotech Plc Sponsored ADR Class A – GETTEX:TRB0 - TradingView
Trinity Biotech stock slips after AI cooling contract rally, trades near 52-week low - AD HOC NEWS
Point of Care Diagnostics Market Forecasts Growth from $20.63B (2026) to $31.46B by 2031, Profiling QuidelOrtho, Sysmex, HemoCue, Trinity Biotech & 15 Other Key Players - Yahoo Finance
Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update - 富途牛牛
Trinity Biotech (NASDAQ: TRIB) tests AI data center liquid cooling in new U.S. pilot deal - Stock Titan
A paid pilot will test Trinity Biotech cooling fluids in AI data centers - Stock Titan
Trinity Biotech Files 2025 Annual Report and AGM Materials with SEC - The Globe and Mail
Shareholders of Trinity Biotech (NASDAQ: TRIB) face key 2026 AGM votes - Stock Titan
Trinity Biotech plcADR Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
TRINITY BIOTECH PLC SEC Filing (Sep 2, 2026) - Stock Titan
Trinity Biotech plcADR Peer Comparison – Compare with Others - valueresearchonline.com
Trinity Biotech plcADR Key Financial Ratios – Valuation, Profitability & More - Value Research
Trinity Biotech expands PrePsia patent portfolio to nine patents - Investing.com
Trinity Biotech expands PrePsia patent portfolio to nine patents By Investing.com - Investing.com India
Trinity Biotech plcADR Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Trinity Biotech (NASDAQ: TRIB) moves to keep Nasdaq listing - Stock Titan
Trinity Biotech (TRIB) pulls 675M unsold shares from $25M standby deal - Stock Titan
Trinity Biotech Updates on Commercial Progress, Manufacturing Transformation, PrePsia Patent Expansion and Nasdaq Compliance - Quiver Quantitative
Trinity Biotech (NASDAQ: TRIB) ends $25M standby share deal - Stock Titan
Echelon’s More Than 700 MW in Development Gets a Cooling Collaborator - Stock Titan
Trinity Biotech (TRIB) makes AI data-center cooling push - Stock Titan
Trinity Biotech secures $7m from Perceptive Advisors - Investing.com
Trinity Biotech Secures Additional $7 Million Investment from Perceptive Advisors and Regains Nasdaq Bid Price Compliance - quiverquant.com
Trinity Biotech Regains Nasdaq Compliance After 10 Days at $1 or More - Stock Titan
Trinity Biotech Secures Additional $7 Million Investment from Perceptive Advisors and Regains Nasdaq Bid Price Compliance - Quiver Quantitative
TRIB,ZBRA Volatility & Greeks - Finviz
Trinity Biotech plc Sponsored ADR Revenue Breakdown – FWB:TRB0 - TradingView
TRIB|Trinity Biotech PLC|Price:6.760|Chg%:-0.190 - TradingKey
Trinity Biotech plc (TRIB) stock price, news, quote and history - Yahoo Finance UK
Trinity Biotech Moves to One-for-Thirty ADS Reverse Split to Meet Nasdaq Bid Price Rules - The Globe and Mail
Trinity Biotech partners with Latch Medical on metabolic health tech - Investing.com
These stocks are moving in today's pre-market session - ChartMill
Trinity Biotech plans 1-for-30 reverse ADS split - Investing.com
Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change - Yahoo Finance
Trinity Biotech Plans Mandatory Exchange of 30 ADSs for 1 on July 24 - Stock Titan
Trinity Biotech Announces 1-for-30 Reverse ADS Split to Regain Nasdaq Compliance | TRIB Stock News - quiverquant.com
Trinity Biotech Partners with Latch Medical to Advance Biosensor-Guided Precision Drug Delivery Solutions Using CGM+ Technology - The Manila Times
Trinity Biotech (NASDAQ: TRIB) plans equity-backed Latch Medical tie-up in CGM-guided drug delivery - Stock Titan
Trinity Biotech (Nasdaq: TRIB) sets 1-for-30 reverse ADS split - Stock Titan
Price to book forward of Trinity Biotech plc Sponsored ADR – FWB:TRB0 - TradingView
Enterprise value to EBIT forward of Trinity Biotech plc Sponsored ADR – FWB:TRB0 - TradingView
Price to earnings forward of Trinity Biotech plc Sponsored ADR – FWB:TRB0 - TradingView
Price to sales forward of Trinity Biotech plc Sponsored ADR – FWB:TRB0 - TradingView
Enterprise value to revenue forward of Trinity Biotech plc Sponsored ADR – FWB:TRB0 - TradingView
Enterprise value to EBITDA forward of Trinity Biotech plc Sponsored ADR – FWB:TRB0 - TradingView
Trinity Biotech CGM+ detects false low glucose alerts during sleep - Investing.com
Trinity Biotech Plc Adr Stock (TRIB) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.35%
4.75%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):